MaxCyte | Laboratory Application Articles and Scientific Posters on SelectScience

Application Notes

Amniocyte Derived Human Cell Line CAP-T® is a Versatile Host for Transient Bulk Transfection

8 Oct 2015

Application Notes

Using Flow Electroporation to Find More Relevant Candidates and Shorten the Antibody Development Timeline

29 Sept 2015

Application Notes

Using the Right Cell for the Right Application: Expanding the Role of Transient Transfection

24 Sept 2015

Application Notes

Shortening the Timeline for Drug Development by Enabling Large-Scale TGE in CHO Cells and High Producing Stable CHO Cell Line

21 Sept 2015

Application Notes

Instant Use of Cryopreserved Cells for Transient Transfection

16 Sept 2015

Application Notes

Accelerating Discovery and Development: Reducing Risk with High Performance Transfection of the Right Cell for the Right Application

2 Mar 2015

Application Notes

Literature Review: CHO versus HEK Cell Glycosylation

2 Mar 2015

Scientific Posters

Antibody Development to Bioproduction Using CHO Transient Gene Expression: Gram/Liter Antibody Titers and Rapid Generation of High Yield, Stable Cell Lines via Flow Electroporation

3 Feb 2015

Scientific Posters

Effects of Cell Density, Aging and Media Formulation on CHO Antibody Expression: Feasibility of Titers >1 g/L

28 Jan 2015

Scientific Posters

Optimization of CHO Transient Gene Expression (TGE) for Multi-Gram Level Antibody Production: Effects of Expression Construct, Post Transfection Cell Density and Feed Conditions

23 Jan 2015

Scientific Posters

Assay Development for Epigenetic Regulation of Histone 3 Lysine 36 Methylation Using AlphaLISA

19 Jan 2015

Scientific Posters

Electroporation as a Cell Transfection Method for High Content Molecular Translocation Assay

14 Jan 2015

Scientific Posters

Universal, Fully Scalable Transfection Platform for Production of Complex or Difficult-to-Express Proteins: Superior Performance over Other Transfection Methods & Expression Systems

8 Jan 2015

Scientific Posters

Streamlined Receptor Screening: Ion Channels, GPCRs and Nuclear Receptor Screening in Biologically Relevant Cells Using Large Scale Transient Transfection

11 Nov 2014

Scientific Posters

Streamlining Antibody Development Using Large Scale, CHO Transient Gene Expression (TGE) Followed by Rapid Production of CHO Stable Pools

7 Nov 2014

Application Notes

Overcoming Obstacles to Develop a Cancer Immunotherapeutic

18 Aug 2014

Scientific Posters

Simple and Effective Generation of Cell-based Assays for Ion Channels, Transporters, and Kinase Screening in Biologically Relevant Cells Using Scalable Transient Transfection

14 Aug 2014

Application Notes

Developing Assays for Screening GPCRs with Transiently Transfected Cells Using the MaxCyte® STX™ System

14 Aug 2014

Application Notes

Keys to Successful Cell-Based Assay Development with the MaxCyte® STX Scalable Transfection System

14 Aug 2014

Scientific Posters

Rapid Production of Proteins, Antibodies, and Vaccines Using Scalable Flow Electroporation: From Plasmid to Protein in Days

14 Aug 2014

Scientific Posters

Scalable, High-Yield Protein Production via Flow Electroporation: Expanding the Use of Transient Gene Expression in Biotherapeutic Development

14 Aug 2014

Application Notes

Flow Electroporation for Vaccine Development and Production: From Subunit Vaccines to Ex Vivo Immunotherapy

7 Aug 2014

White Papers

Scalable Protein Production Using Flow Electroporation

19 May 2014

White Papers

Flow Electroporation Capabilities and Case Studies: Rapid GPCR Screening and Functional Ion Channel Assays

19 May 2014

Scientific Posters

CAR mRNA Loaded Freshly Isolated Peripheral Blood Lymphocytes as Rapid, Targeted Tumor Immunotherapy

18 May 2014

Resources

Resources Filter

Search

Selected Filters:

Amniocyte Derived Human Cell Line CAP-T® is a Versatile Host for Transient Bulk Transfection

Using Flow Electroporation to Find More Relevant Candidates and Shorten the Antibody Development Timeline

Using the Right Cell for the Right Application: Expanding the Role of Transient Transfection

Shortening the Timeline for Drug Development by Enabling Large-Scale TGE in CHO Cells and High Producing Stable CHO Cell Line

Instant Use of Cryopreserved Cells for Transient Transfection

Accelerating Discovery and Development: Reducing Risk with High Performance Transfection of the Right Cell for the Right Application

Literature Review: CHO versus HEK Cell Glycosylation

Antibody Development to Bioproduction Using CHO Transient Gene Expression: Gram/Liter Antibody Titers and Rapid Generation of High Yield, Stable Cell Lines via Flow Electroporation

Effects of Cell Density, Aging and Media Formulation on CHO Antibody Expression: Feasibility of Titers >1 g/L

Optimization of CHO Transient Gene Expression (TGE) for Multi-Gram Level Antibody Production: Effects of Expression Construct, Post Transfection Cell Density and Feed Conditions

Assay Development for Epigenetic Regulation of Histone 3 Lysine 36 Methylation Using AlphaLISA

Electroporation as a Cell Transfection Method for High Content Molecular Translocation Assay

Universal, Fully Scalable Transfection Platform for Production of Complex or Difficult-to-Express Proteins: Superior Performance over Other Transfection Methods & Expression Systems

Streamlined Receptor Screening: Ion Channels, GPCRs and Nuclear Receptor Screening in Biologically Relevant Cells Using Large Scale Transient Transfection

Streamlining Antibody Development Using Large Scale, CHO Transient Gene Expression (TGE) Followed by Rapid Production of CHO Stable Pools

Overcoming Obstacles to Develop a Cancer Immunotherapeutic

Simple and Effective Generation of Cell-based Assays for Ion Channels, Transporters, and Kinase Screening in Biologically Relevant Cells Using Scalable Transient Transfection

Developing Assays for Screening GPCRs with Transiently Transfected Cells Using the MaxCyte® STX™ System

Keys to Successful Cell-Based Assay Development with the MaxCyte® STX Scalable Transfection System

Rapid Production of Proteins, Antibodies, and Vaccines Using Scalable Flow Electroporation: From Plasmid to Protein in Days

Scalable, High-Yield Protein Production via Flow Electroporation: Expanding the Use of Transient Gene Expression in Biotherapeutic Development

Flow Electroporation for Vaccine Development and Production: From Subunit Vaccines to Ex Vivo Immunotherapy

Scalable Protein Production Using Flow Electroporation

Flow Electroporation Capabilities and Case Studies: Rapid GPCR Screening and Functional Ion Channel Assays

CAR mRNA Loaded Freshly Isolated Peripheral Blood Lymphocytes as Rapid, Targeted Tumor Immunotherapy

Resources

Resources FilterResources Filter

Search

Selected Filters:

Amniocyte Derived Human Cell Line CAP-T® is a Versatile Host for Transient Bulk Transfection

Using Flow Electroporation to Find More Relevant Candidates and Shorten the Antibody Development Timeline

Using the Right Cell for the Right Application: Expanding the Role of Transient Transfection

Shortening the Timeline for Drug Development by Enabling Large-Scale TGE in CHO Cells and High Producing Stable CHO Cell Line

Instant Use of Cryopreserved Cells for Transient Transfection

Accelerating Discovery and Development: Reducing Risk with High Performance Transfection of the Right Cell for the Right Application

Literature Review: CHO versus HEK Cell Glycosylation

Antibody Development to Bioproduction Using CHO Transient Gene Expression: Gram/Liter Antibody Titers and Rapid Generation of High Yield, Stable Cell Lines via Flow Electroporation

Effects of Cell Density, Aging and Media Formulation on CHO Antibody Expression: Feasibility of Titers >1 g/L

Optimization of CHO Transient Gene Expression (TGE) for Multi-Gram Level Antibody Production: Effects of Expression Construct, Post Transfection Cell Density and Feed Conditions

Assay Development for Epigenetic Regulation of Histone 3 Lysine 36 Methylation Using AlphaLISA

Electroporation as a Cell Transfection Method for High Content Molecular Translocation Assay

Universal, Fully Scalable Transfection Platform for Production of Complex or Difficult-to-Express Proteins: Superior Performance over Other Transfection Methods & Expression Systems

Streamlined Receptor Screening: Ion Channels, GPCRs and Nuclear Receptor Screening in Biologically Relevant Cells Using Large Scale Transient Transfection

Streamlining Antibody Development Using Large Scale, CHO Transient Gene Expression (TGE) Followed by Rapid Production of CHO Stable Pools

Overcoming Obstacles to Develop a Cancer Immunotherapeutic

Simple and Effective Generation of Cell-based Assays for Ion Channels, Transporters, and Kinase Screening in Biologically Relevant Cells Using Scalable Transient Transfection

Developing Assays for Screening GPCRs with Transiently Transfected Cells Using the MaxCyte® STX™ System

Keys to Successful Cell-Based Assay Development with the MaxCyte® STX Scalable Transfection System

Rapid Production of Proteins, Antibodies, and Vaccines Using Scalable Flow Electroporation: From Plasmid to Protein in Days

Scalable, High-Yield Protein Production via Flow Electroporation: Expanding the Use of Transient Gene Expression in Biotherapeutic Development

Flow Electroporation for Vaccine Development and Production: From Subunit Vaccines to Ex Vivo Immunotherapy

Scalable Protein Production Using Flow Electroporation

Flow Electroporation Capabilities and Case Studies: Rapid GPCR Screening and Functional Ion Channel Assays

CAR mRNA Loaded Freshly Isolated Peripheral Blood Lymphocytes as Rapid, Targeted Tumor Immunotherapy

Resources Filter